Toshiba announces FDA OK for Infinix VC-i system

Toshiba America Medical Systems is offering a new dedicated vascular system, the Infinix VC-i with large field of view (LFOV) Flat Panel Detector (FPD) that just received FDA 510(k) clearance. The company made the announcement at RSNA 2005 in Chicago.
   
The Infinix VC-i's new LFOV FPD technology is designed to streamline workflow through an all-digital system, to produce high-quality clear images and to increase efficiency for vascular exams. The system is designed to provide distortion-free imaging with uniform brightness plus advanced technologies, including powerful digital acquisition, processing and storage to offer immediate access to images and cost-effective archiving, according to Toshiba.

Besides those features, the system includes dose management functions, which ensure high-quality images at the lowest possible dose, easy-to-use tableside controls, flexible tabletop design and a liquid metal x-ray tube.  The LFOV FPD is available as a field-upgradeable component for existing Infinix VC-i systems.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.